PAX8 and intrahepatic cholangiocarcinoma: Moreover, our results indicated that in the absence of drug treatment, PAX8‐AS1 had no significant effect on the proliferation and death of ICC cells (both in vitro and in vivo) (Figures S3A–I and S5B–D, Supporting Information) and PDOs (Figure S5A, Supporting Information).